K
Kyntra Bio, Inc. (KYNB)
NMS – Real Time Price. Currency in USD
7.24
+0.30 (4.32%)
At close: Jun 26, 2026, 4:00 PM EDT
7.24
0.00 (0.00%)
After-hours: Jun 26, 2026, 5:49 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
7.24
+0.30 (4.32%)
At close: Jun 26, 2026, 4:00 PM EDT
7.24
0.00 (0.00%)
After-hours: Jun 26, 2026, 5:49 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $37.0M significantly exceed its total debt $19.2M, ensuring strong financial flexibility
Total current assets $101.4M exceed Total current liabilities $28.1M, highlighting excellent liquidity
Debt-to-equity ratio (-2.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-5.7x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$13.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.61 | 6.05 | 10 | |
| Quick ratio | 3.48 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.18 | 1.04 | 8.0 | |
| Interest coverage | -5.68 | -16.91 | 1.0 | |
| Weighted average score | 6.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 141M | 47M | 30M | 6M | 7M |
| Gross Profit | 120M | 36M | 14M | 5M | 3M |
| Operating Income | -301M | -310M | -131M | -45M | -44M |
| Net Income | -294M | -284M | -48M | 131M | 111M |
| EBITDA | -290M | -300M | -128M | -45M | -44M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 3.46 | -74.04 | 2.5 |
| Next quarter | 27.79 | -106.82 | 5.5 |
| Current year | 24.13 | -130.61 | 5.5 |
| Next year | -15.66 | 29.95 | 5.5 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 192.72 | -3.56 | -7.11 | 24.23 | 5.5 |
| Y/Y | 36.47 | -426.18 | -400.79 | -622.65 | 3.3 |
| 3y average | -60.55 | 153.86 | 189.55 | 13.6 | 7.3 |
| 5y average | -37.67 | 81.43 | 103.97 | -48.6 | 5.5 |
| Weighted average score | 5.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |